Search Within

Avni Mukund Desai

Formats
  1. Journal Article (14)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (21)
  2. Gastrointestinal Oncology Service (21)
  3. Solid Tumor Oncology Division (21)
  4. Center for Pancreatic Cancer Research (19)
  5. Survivorship Research (15)
  6. Hematologic Malignancies, Division of (14)

More Groups

People
  1. Geoffrey Ku (12)
  2. Yelena Janjigian (11)
  3. David Ilson (9)
  4. Joanne Chou (8)
  5. Marinela Capanu (8)
  6. Zoe Goldberg (8)

More People

Years
  1. 2025 (2)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Nature (2)
  3. New England Journal of Medicine (2)
  4. Annals of Oncology (1)
  5. BMC Cancer (1)
  6. Cancer Biology and Medicine (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Massachusetts Medical Society (2)
  3. Nature Publishing Group (2)
  4. Oxford University Press (2)
  5. Springer (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nonoperative management of mismatch repair-deficient tumors
    Journal Article

    Cercek, A.; Foote, M. B.; Rousseau, B.; Smith, J. J.; Shia, J.; Sinopoli, J.; Weiss, J.; Lumish, M.; Temple, L.; Patel, M.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
    Journal Article

    Sethna, Z.; Guasp, P.; Reiche, C.; Milighetti, M.; Ceglia, N.; Patterson, E.; Lihm, J.; Payne, G.; Lyudovyk, O.; Rojas, L. A.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
    Journal Article

    Rojas, L. A.; Sethna, Z.; Soares, K. C.; Olcese, C.; Pang, N.; Patterson, E.; Lihm, J.; Ceglia, N.; Guasp, P.; Chu, A.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Clinical importance of clonal hematopoiesis in metastatic gastrointestinal tract cancers
    Journal Article

    Diplas, B. H.; Ptashkin, R.; Chou, J. F.; Sabwa, S.; Foote, M. B.; Rousseau, B.; ArgileĢs, G.; White, J. R.; Stewart, C. M.; Bolton, K.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)
    Meeting Abstract

    Cytryn, S.; Joshi, S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; Rao, D.; Goldberg, Z.; Sugarman, R.; Antoine, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • The frequency of second primary malignancies and colonic polyps in Lynch syndrome with MSI tumors following immune checkpoint blockade
    Meeting Abstract

    Harrold, E.; Patel, Z.; Maio, A.; Cercek, A.; Yaeger, R.; Segal, N. H.; Reidy, D. L.; O'Reilly, E. M.; Desai, A. M.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer
    Journal Article

    Cercek, A.; Lumish, M.; Sinopoli, J.; Weiss, J.; Shia, J.; Lamendola-Essel, M.; El Dika, I. H.; Segal, N.; Shcherba, M.; Sugarman, R.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • PD-1 blockade alone for mismatch repair deficient (dMMR) locally advanced rectal cancer
    Meeting Abstract

    Lumish, M. A.; Cohen, J. L.; Stadler, Z. K.; Weiss, J. A.; Lamendola-Essel, M. F.; Yaeger, R.; Segal, N. H.; El Dika, I. H.; Saltz, L. B.; Shcherba, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma
    Journal Article

    Moy, R. H.; Greally, M.; Chou, J. F.; Li, J.; Desai, A. M.; Chalasani, S. B.; Won, E.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; more...
    Cancer Chemotherapy and Pharmacology (2022)

    Fulltext@MSK | Save